Contemporary Management of Staphylococcus aureus Bacteremia—Controversies in Clinical Practice

DJ Minter, A Appa, HF Chambers… - Clinical Infectious …, 2023 - academic.oup.com
Staphylococcus aureus bacteremia (SAB) carries a high risk for excess morbidity and
mortality. Despite its prevalence, significant practice variation continues to permeate clinical …

Antibiotic myths for the infectious diseases clinician

EK McCreary, MD Johnson, TM Jones… - Clinical Infectious …, 2023 - academic.oup.com
Antimicrobials are commonly prescribed and often misunderstood. With more than 50% of
hospitalized patients receiving an antimicrobial agent at any point in time, judicious and …

Heartbreaking decisions: The dogma and uncertainties of antimicrobial therapy in infective endocarditis

JL Adema, A Ahiskali, M Fida, K Mediwala Hornback… - Pathogens, 2023 - mdpi.com
Infective endocarditis (IE) is a rare but increasingly prevalent disease with high morbidity
and mortality, requiring antimicrobials and at times surgical intervention. Through the …

Cefazolin and its photodegradation products–Prediction of pharmacokinetic profile and ecotoxicological potential

J Żandarek, P Żmudzki, D Obradović, S Lazović… - Journal of …, 2025 - Elsevier
Understanding the behavioral pathways of xenobiotics in the environment allows for the
assessment of the risk to humans resulting from their presence. The aim of the study was to …

Optimal drug therapy for Staphylococcus aureus bacteraemia in adults

A Legg, JS Davis, JA Roberts - Current Opinion in Critical Care, 2023 - journals.lww.com
Optimal drug therapy for Staphylococcus aureus bacteraemia i... : Current Opinion in Critical
Care Optimal drug therapy for Staphylococcus aureus bacteraemia in adults : Current Opinion …

Treatment of Complicated Gram-Positive Bacteremia and Infective Endocarditis

P Schellong, O Joean, MW Pletz, S Hagel, S Weis - Drugs, 2024 - Springer
Abstract The Gram-positive cocci Staphylococcus aureus, Streptococcus spp., and
Enterococcus spp. are the most frequent causative organisms of bloodstream infections and …

[HTML][HTML] Rationale and Logistics of Continuous Infusion Cephalosporin Antibiotics

AL Blunier, RJ Crocker, R Foster, SS May, CE Powers… - Pharmacy, 2024 - mdpi.com
Cephalosporins have traditionally been administered as an intermittent infusion. With the
knowledge that cephalosporins demonstrate a time-dependent pharmacodynamic profile …

Cefazolin for the Treatment of Central Nervous System Infections

AR Tunkel - Clinical Infectious Diseases, 2024 - academic.oup.com
TO THE EDITOR—I read with interest the recent article “Antibiotic Myths for the Infectious
Diseases Clinician” by McCreary et al [1]. I want to comment specifically on the myth that …

Central nervous system infections and antibiotic selection: all infection sites are not created equal

KJ Goodlet, MD Nailor - Clinical Infectious Diseases, 2023 - academic.oup.com
TO THE EDITOR—We read with interest the article by McCreary et al [1], which discussed
pharmacologic “myths” relevant to infectious disease clinical practice, including the use of …

[HTML][HTML] ''Myth Busting in Infectious Diseases'': A Comprehensive Review

A Almajid, S Almuyidi, S Alahmadi, S Bohaligah… - Cureus, 2024 - ncbi.nlm.nih.gov
Antibiotics have played a pivotal role in modern medicine, drastically reducing mortality
rates associated with bacterial infections. Despite their significant contributions, the …